<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - Protection of public health from endocrine disrupters (A7-0027/2013 - Åsa Westlund) - Thursday, 14 March 2013</title><meta name="title" content="Verbatim report of proceedings - Protection of public health from endocrine disrupters (A7-0027/2013 - Åsa Westlund) - Thursday, 14 March 2013" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2013 - Source: European Parliament" /><meta name="available" content="14-03-2013" /><meta name="sipade-leg" content="7" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - Protection of public health from endocrine disrupters (A7-0027/2013 - Åsa Westlund) - Thursday, 14 March 2013" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-7-2013-03-14-ITM-009-18_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li><a title="bg - български" class="bg on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_BG.html">bg - български</a></li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_FR.html">fr - français</a></li>
            <li class="ga" title="ga - Gaeilge">ga - Gaeilge</li>
            <li class="hr" title="hr - hrvatski">hr - hrvatski</li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_PT.html">pt - português</a></li>
            <li><a title="ro - română" class="ro on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_RO.html">ro - română</a></li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-7-2013-03-14-ITM-009-18_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-7-2013-03-14-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-7-2013-03-14-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-7-2013-03-14-ITM-009-17_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-7-2013-03-14-ITM-009-17_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-7-2013-03-14-ITM-009-19_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-7-2013-03-14-ITM-009-19_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-7-2013-03-14_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-7-2013-03-14_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table>
                <table border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td align="left"><span class="contents">Procedure : </span><a class="ring_ref_link" href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2012/2066(INI)">2012/2066(INI)</a></td><td align="right"><table align="right" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><img src="/doceo/data/img/ring_tabs_left_doc_unselected.gif" height="19" width="4" alt="" /></td><td class="Tabs_doc_unselected"><img src="/doceo/data/img/ring_navi.gif" width="17" height="14" alt="" />Document stages in plenary</td><td valign="middle"><img src="/doceo/data/img/ring_tabs_right_doc_unselected.gif" height="19" width="4" alt="" /></td></tr></tbody></table></td></tr></tbody></table><table class="doc_box_header" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td class="ring_multiple_bg" valign="top" colspan="7">Document selected :
            <span class="ring_ref_selected_header">A7-0027/2013</span></td></tr><tr><td width="25%" valign="top" class="ring_step_bg1" nowrap="nowrap"><p class="ring_step_title">Texts tabled :</p>
                        <a href="/doceo/document/A-7-2013-0027_EN.html" class="ring_ref_link">A7-0027/2013</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg1.gif)"><img src="/doceo/data/img/ring_flech1.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg2" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Debates :</p>
                        <a href="/doceo/document/PV-7-2013-03-12-ITM-019_EN.html" class="ring_ref_link">PV 12/03/2013 - 19</a><br />
                        <a href="/doceo/document/CRE-7-2013-03-12-ITM-019_EN.html" class="ring_ref_link">CRE 12/03/2013 - 19</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg2.gif)"><img src="/doceo/data/img/ring_flech2.gif" width="13" height="22" border="0" alt="" /></td><td class="ring_step_bg3" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Votes :</p>
                        <a href="/doceo/document/PV-7-2013-03-14-ITM-008-04_EN.html" class="ring_ref_link">PV 14/03/2013 - 8.4</a><br />
                        <a class="ring_ref_selected">Explanations of votes</a><br />
                    </td><td width="19" style="background-image:url(/doceo/data/img/ring_bg3.gif)"><img src="/doceo/data/img/ring_flech3.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg4" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Texts adopted :</p>
                        <a href="/doceo/document/TA-7-2013-0091_EN.html" class="ring_ref_link">P7_TA(2013)0091</a><br />
                    </td></tr></tbody></table><br />
            <table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)"></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Thursday, 14 March 2013 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">Revised edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 9.18. Protection of public health from endocrine disrupters (<a href="/doceo/document/A-7-2013-0027_EN.html">A7-0027/2013</a> - Åsa Westlund) </td><td style="background-image:url(/doceo/data/img/gradient_blue.gif)" width="10"><table cellSpacing="0" cellPadding="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20130314-13:04:34&amp;playerEndTime=20130314-13:05:57" target="_blank"><img width="29" height="20" src="/doceo/data/img/vod_all_speakers_left.gif" border="0" /></a></td><td class="switch_button_pv_cre"><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20130314-13:04:34&amp;playerEndTime=20130314-13:05:57" target="_blank">Video of the speeches</a></td><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=chapter&amp;vodLanguage=EN&amp;playerStartTime=20130314-13:04:34&amp;playerEndTime=20130314-13:05:57" target="_blank"><img width="5" height="20" src="/doceo/data/img/switch_pv_cre_right.gif" border="0" /></a></td></tr></table></td></tr></table>
<a name="4-329-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20130314-13:04:38&amp;playerEndTime=20130314-13:04:44" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="bold">Mündliche Erklärungen zur Abstimmung</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-330-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4521.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20130314-13:04:44&amp;playerEndTime=20130314-13:05:50" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Charles Tannock (ECR). -</span></span>   Mr President, we all strive to protect our constituents from undue harm when possible. Health risks certainly fall within this remit.</p>
<p class="contents">When addressing these risks, it is our duty to assess them logically and react according to the seriousness of the risk. This report on endocrine disrupters would apply drastic precautions that are disproportionate to the reality of the known science on the subject. </p>
<p class="contents">How can we take action against substances that are not yet even scientifically defined, or detected in sufficient quantities in our food chains? The report contradicts itself, admitting that scientific knowledge of the risk of endocrine disrupters is currently limited, but claiming that all endocrine-disrupting chemicals have adverse effects, even at the very lowest of exposures.</p>
<p class="contents">While prevention is of the utmost importance when it comes to matters of health, such measures must be proportionate and based on science. The precautions prescribed by this report are neither, and are, I fear, a great overreaction to a still unclear threat. </p>
<p class="contents">While we must be vigilant and continue to explore the role of endocrine disrupters on health, we must do so pragmatically and responsibly. We must also think of the economic consequences of reacting disproportionately in these matters. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0"><tr><td><a title="Video of the speeches" href="/plenary/en/vod.html?mode=unit&amp;vodLanguage=EN&amp;playerStartTime=20130314-13:05:49&amp;playerEndTime=20130314-13:05:59" target="_blank"><img width="26" height="24" src="/doceo/data/img/vod_one_speaker.gif" border="0" /></a></td></tr></table></td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="bold">Schriftliche Erklärungen zur Abstimmung</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-007"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96976.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Luís Paulo Alves (S&amp;D), </span></span>  <span class="italic">por escrito</span>. <span class="bold">−</span> Aprovo o presente relatório, considerando haver razões para encarar com a maior seriedade o aumento dos distúrbios e doenças hormonais no ser humano. O sistema endócrino regula muito do que acontece no corpo, nomeadamente, a reprodução, o metabolismo, o crescimento, o equilíbrio entre sal e água e a função cardíaca. Assiste-se a uma tendência preocupante, sobretudo no que se refere à capacidade reprodutiva do ser humano, e acredita-se que os desreguladores endócrinos desempenham um papel determinante. O princípio da precaução é e deve continuar a ser um pilar importante da política da UE em matéria de produtos químicos. O facto de não sabermos tudo não pode ser usado como pretexto para a inação. Os riscos de danos irreversíveis nos seres humanos e no ambiente são, simplesmente, demasiado grandes. Atualmente, existem cerca de 27.000 relatórios de investigação que tratam dos desreguladores endócrinos e dos seus efeitos nos seres humanos e nos animais, mas continuamos a assistir a uma série de tendências preocupantes.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-011"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28276.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Laima Liucija Andrikienė (PPE), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> The endocrine is one of the most important systems in the body. The endocrine system regulates much of what happens in the body, including reproduction, metabolism, growth, salt and water balance and cardiac function. Taking into account the fact that during the past 20 years, hormone-related disorders and illnesses like cancer, obesity, diabetes and cardiovascular diseases have increased and that endocrine disrupters are classified as risk factors for health, I voted in favour of this report because the protection of human health is an important EU policy. Moreover, it is very important to make clear what is regarded as a substance with endocrine-disrupting properties, and criteria determining what constitutes an endocrine disrupter must be scientifically based. It is important to provide support for up-to-date research. I truly believe that protection of human health must be effective – to restrict the use of endocrine disruptors in products, such as cosmetics, toys, furniture, building products, food, etc. The fact that we do not know everything cannot be used as a pretext for inactivity.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-013"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96862.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sophie Auconie (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> J'ai voté en faveur de ce rapport qui demande que l’Union européenne agisse pour protéger la santé des citoyens face aux perturbateurs endocriniens, ces substances chimiques qui interfèrent avec le système hormonal. Nous sommes quasi quotidiennement en contact avec ces perturbateurs endocriniens pouvant se trouver dans les plastiques, dans des cosmétiques, la peinture ou les emballages alimentaires. Il convient de se montrer prudent face aux dommages sanitaires pouvant être causés par les perturbateurs endocriniens, comme des cancers du sein ou la baisse de la fertilité masculine. C'est pourquoi nous voulons inclure ces substances potentiellement dangereuses sous le couvert du règlement REACH (Enregistrement, évaluation et autorisation limitée des produits chimiques) pour s'assurer d'une information et de méthodes d'évaluation appropriées.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-014"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96680.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Zigmantas Balčytis (S&amp;D), </span></span>  <span class="italic">raštu</span><span class="bold">. − </span>Balsavau už šį siūlymą dėl visuomenės sveikatos apsaugos nuo hormonus ardančių medžiagų (HAM). Tokio tipo medžiagos aptinkamos kosmetikoje, balduose, elektronikos prekėse, statybiniuose ir tekstilės gaminiuose bei maisto produktuose. Jų poveikis daro neigiamą įtaką žmogaus reprodukcijai, medžiagų apykaitai bei širdžiai. Siūlymo tikslas – patikslinti turimas mokslines žinias apie šių medžiagų poveikį žmonėms bei jį sumažinti. Pritariu išdėstytiems siūlymams šių medžiagų naudojimą apriboti gaminiuose, skirtuose konkrečioms tikslinėms grupėms: vaikams, jaunimui, nėščioms moterims. Svarbu taikyti griežtesnius saugumo reikalavimus įrengiant ikimokyklinio ugdymo patalpas ir mokyklas bei sumažinti endokrininę sistemą ardančioms medžiagoms išduodamų leidimų skaičių. Būtina priskirti HAM prie labai didelį susirūpinimą keliančių medžiagų REACH reglamente ir galiojančiose ES teisės aktuose nustatyti tyrimų reikalavimus, kuriais remiantis būtų nustatomos HAM. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-015"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/113883.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Erik Bánki (PPE), </span></span>  <span class="italic">írásban</span><span class="bold">. −</span> Az endokrin rendszer működése kulcsfontosságú szervezetünk működése szempontjából. Belső elválasztású mirigyeink olyan hormonokat termelnek, amelyek a központi idegrendszerben ingerületátvivő szerepet töltenek be. Olyan kulcsterületek függenek tőle, mint a szaporodás, a növekedés és egyedfejlődés, valamint a szervezet működéséhez nélkülözhetetlen energiaforgalom. Az endokrin szabályozásban a visszacsatolási elv érvényesül, azaz a szabályozó hormon termelődése növekszik, amint a szabályozott hormon szintje a szervezetben csökken. Rendkívül fontos, ugyanakkor összetett és sérülékeny az endokrin rendszer. Korunk súlyos problémája annak a számtalan szennyező anyagnak a káros hatása, mely nap mint nap ér bennünket. A Bizottságnak ezért ki kell dolgoznia az endokrinromboló anyagok által hordozott kockázatok nagyobb mértékű figyelembevételéhez szükséges jogszabályi hátteret. Különösen fontos az azon anyagokra vonatkozó előírások köre, amelyekkel a gyermekek érintkeznek, pl. textíliák, játékok, csomagolóanyagok, hiszen gyermekeink kitettsége a legnagyobb az endokrin rendszert károsító anyagokkal szemben. Különösen ezen okok miatt támogattam szavazatommal a jelentést.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-023"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28214.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean-Luc Bennahmias (ALDE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Par rapport à des produits chimiques bien identifiés, les perturbateurs endocriniens restent méconnus, à la fois des populations et des législations, nationale comme européenne. Les perturbateurs endocriniens sont des molécules chimiques que l'on retrouve partout - dans notre environnement et dans beaucoup d'objets de notre quotidien -et qui auraient un impact sur notre système endocrinien et sur notre santé. Le rapport d'initiative adopté aujourd'hui par le Parlement européen alerte sur les dangers et la nécessité de mieux prendre en compte ces molécules chimiques. Etant donné leur présence diffuse, le lien de cause à effet entre une substance supposée perturbatrice et ses effets sur la santé reste très difficile à établir. Cependant, dans ce rapport nous appelons la Commission européenne à réviser sa stratégie sur ce sujet et notamment à présenter des propositions de critères généraux fondés sur la définition élaborée par l'Organisation Mondiale de la Santé et à introduire dans l'UE une définition claire des substances "perturbatrices". Enfin, nous l'appelons à concentrer ses efforts sur l'information et la sensibilisation des populations à l'existence de ces substances et à leurs effets potentiels.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-031"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4746.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sergio Berlato (PPE), </span></span>  <span class="italic">per iscritto</span><span class="bold">. −</span> L’articolo 35 del trattato sottolinea come la tutela della salute umana costituisca un elemento importante della politica dell'Unione europea. Dagli attuali rapporti di ricerca sugli interferenti endocrini e sui loro effetti sugli esseri umani e sugli animali emerge una tendenza preoccupante: negli ultimi vent'anni si registra un drastico aumento a livello globale di disturbi legati agli ormoni. Il problema principale è che gli interferenti endocrini si trovano ovunque nel nostro quotidiano: negli imballaggi alimentari, nei prodotti per la cura della pelle, nei cosmetici, nei materiali per l'edilizia, nelle apparecchiature elettroniche, nei mobili e, pertanto, per i consumatori è impossibile sapere quali sostanze siano presenti nei singoli prodotti, in particolare, per quelli per i quali non è obbligatorio dichiarare il contenuto. Considerato che uno dei capisaldi della politica dell'Unione europea in materia di sostanze chimiche è il principio di precauzione, concordo con il relatore nel sollecitare la Commissione ad adottare, innanzitutto, tutte le opportune misure per rafforzare i criteri in materia di sicurezza per i cittadini. È particolarmente importante, a mio avviso, che gli interferenti endocrini siano segnalati nelle sostanze chimiche per quelle categorie di prodotti - come i prodotti tessili - con cui vengono a contatto soprattutto i bambini.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-046"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97198.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mara Bizzotto (EFD), </span></span>  <span class="italic">per iscritto</span><span class="bold">. −</span> Non ho sostenuto la relazione Westlund sulla "Protezione della salute pubblica dagli interferenti endocrini". Ritengo che questo testo sia eccessivamente allarmista e sbilanciato, portando a considerare le reazioni del sistema endocrino alle sostanze chimiche (naturali o di sintesi) come pericolose a priori. Servono posizioni più ponderate, è fondamentale che la legislazione vigente preveda test di individuazione adeguati, secondo criteri basati su una completa valutazione dei rischi.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-062"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96681.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Vilija Blinkevičiūtė (S&amp;D), </span></span>  <span class="italic">raštu</span><span class="bold">. −</span> Balsavau už šį pranešimą, nes per pastaruosius 20 metų padaugėjo žmonių hormoninės sistemos sutrikimų ir ligų, įskaitant ankstyvą lytinį brendimą, daugiau deformuotų lytinių organų atvejų, daugiau tam tikrų vėžio formų atvejų ir medžiagų apykaitos ligų. Vis daugiau mokslinių tyrimų rodo, kad endokrininę sistemą ardančios cheminės medžiagos ir jų deriniai daro poveikį tiek lėtinėms ligoms, įskaitant su hormonų sistema susijusias vėžio formas, nutukimą, cukrinį diabetą, širdies ir kraujagyslių ligas, tiek reprodukcijos problemoms. Turi būti kuo greičiau pateikti pasiūlymai dėl endokrininę sistemą ardančių cheminių medžiagų apibrėžimų ir tyrimų, taip pat informacijos reikalavimų, taikytinų komercinėje rinkoje tiekiamoms cheminėms medžiagoms, ir dėl ES teisės akto, kuriuo būtų išaiškinama, kas laikoma endokrininę sistemą ardančių savybių turinčia medžiaga. Remiantis turimais moksliniais duomenimis, nėra pakankamo pagrindo, kaip nustatyti ribines vertes, kurių neviršijus nedaroma jokio poveikio, taigi endokrininę sistemą ardančios medžiagos turėtų būti laikomos ribinės vertės neturinčiomis medžiagomis ir bet koks tokių medžiagų poveikis gali būti pavojingas. ES pirmenybė turi būti teikiama moksliniams tyrimams finansuoti, siekiant tirti hormonų sistemą ardančių medžiagų poveikį sveikatai, ir remti ilgalaikius tyrimus, sudarant sąlygas atlikti įrodymais pagrįstą endokrininę sistemą ardančių medžiagų ilgalaikio poveikio ir poveikio kelioms kartoms vertinimą.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-093"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/105624.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Philippe Boulland (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> J'ai voté en faveur du rapport qui vise à réduire l'exposition aux perturbateurs endocriniens suspectés d'affecter les hormones. C'est un signal fort que nous avons envoyé à la Commission, pour qu'elle propose des critères pour définir et évaluer ces perturbateurs. Même si nous n'avons pas encore toutes les réponses sur la toxicité de ces produits, le principe de précaution nous obligeait à agir pour réglementer ces substances préoccupantes et protéger la santé des citoyens européens.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-109"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/38420.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Cristian Silviu Buşoi (ALDE), </span></span>  <span class="italic">în scris</span><span class="bold">. − </span>Am votat în favoarea acestui raport. Tulburările şi bolile endocrine au cunoscut o creştere în întreaga lume, iar numeroase studii consideră perturbatorii endocrini ca fiind un factor care a contribuit la această tendinţă. Perturbatorii endocrini au fost asociaţi de-a lungul timpului cu mai multe probleme de sănătate, cum ar fi malformaţii ale sistemului de reproducere, congenitale sau tulburări ale dezvoltării neurologice (autism). Lucrul îngrijorător este faptul că perturbatorii endocrini se regăsesc într-o arie extinsă de produse, începând cu ambalajele alimentelor pe care le cumpărăm şi terminând cu unele produse electronice fără de care mulţi dintre noi nu ne-am putea desfăşura activităţile zilnice (telefonul sau laptopul). Protecţia sănătăţii umane este unul dintre pilonii politicii comunitare, iar în acest caz principiul precauţiei trebuie să fie întru totul aplicat. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96849.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alain Cadec (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> J'ai voté en faveur du rapport Westlund. Pour contrer la menace grandissante que font peser les perturbateurs endocriniens sur la santé publique, j'approuve les mesures proposées par la rapporteure. J'estime en effet que l'identification de la présence des perturbateurs endocriniens dans les produits et objets de la vie quotidienne permettra aux plus exposés de mieux se prémunir contre certains cancers et troubles neurologiques.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/26851.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Νικόλαος Χουντής (GUE/NGL), </span></span>  <span class="italic">γραπτώς</span><span class="bold">. – </span>Ψήφισα υπέρ της έκθεσης Westlund, γιατί αναγνωρίζει τις επιπτώσεις των ενδοκρινικών διαταρακτών στην υγεία, τις παθογένειες που προκαλούν και την ανάγκη άμεσης δραστηριοποίησης στον τομέα της πολιτικής των χημικών ουσιών. Σύμφωνα με έρευνα του Ευρωβαρόμετρου στις 27 χώρες της ΕΕ, το 83% των καταναλωτών ανησυχεί ότι τα τρόφιμα και ποτά που καταναλώνει περιέχουν χημικές ουσίες, ενώ σε ποσοστά που κυμαίνονται από 74 έως 90% εκφράζεται η ανησυχία ότι υπάρχουν χημικές ουσίες στα καλλυντικά, στα ρούχα, στα έπιπλα και κυρίως σε παιχνίδια και προϊόντα φροντίδας παιδιών. Η υφιστάμενη νομοθεσία της ΕΕ βασίζεται στην προσέγγιση της αξιολόγησης ανά χημική ουσία χωριστά. Σήμερα όμως γνωρίζουμε ότι οι ενδοκρινικοί διαταράκτες δρουν ακόμη και σε πολύ χαμηλές δόσεις και ότι θα πρέπει να λαμβάνουμε υπόψη τις συνδυασμένες επιδράσεις τους. Γι’ αυτό και απαιτούνται περαιτέρω δράσεις στον τομέα της πολιτικής των χημικών ουσιών, των μεθόδων έρευνας και αξιολόγησης για την αντιμετώπιση των συνδυασμένων επιδράσεων των χημικών ουσιών.</p>
<p class="contents">Η Ευρωπαϊκή Επιτροπή θα πρέπει να επανεξετάσει τη στρατηγική της για τους ενδοκρινικούς διαταράκτες βασιζόμενη στην αρχή της προφύλαξης. Έχοντας ως βασικό στόχο την κατοχύρωση της ασφάλειας των καταναλωτών, ιδιαίτερα των ευάλωτων ομάδων, να ακολουθήσει το παράδειγμα της Δανίας, που απαγόρευσε τη διφαινόλη Α σε συσκευασίες τροφίμων και καλλυντικά για παιδιά.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/113597.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Minodora Cliveti (S&amp;D), </span></span>  <span class="italic">în scris</span><span class="bold">. −</span> Perturbatorii sistemului endocrin sunt tot mai mult recunoscuţi ca reprezentând o provocare majoră pentru sănătatea umană şi pentru mediu. Ei au fost adesea corelaţi cu o serie de probleme grave de sănătate, precum cancerul, diabetul zaharat, disfuncţii imunitare, obezitate, disfuncţii reproductive, boli cardiovasculare, modificări de comportament şi pubertate precoce. </p>
<p class="contents">Criza financiară este adesea menţionată ca principalul obstacol în elaborarea unor noi măsuri legislative. Este nevoie de o descriere mai exactă şi mai precisă a naturii riscurilor pentru a decide unde să poziţionăm această problemă în ceea ce priveşte nivelul de prioritate şi de alocare a resurselor. Principiul precauţiei ne cere ca, în acest context de incertitudine ştiinţifică, să luăm măsuri adecvate pentru a evita sau reduce consecinţele posibil grave sau ireversibile pentru sănătatea umană şi mediu, prin introducerea şi menţinerea unor programe de cercetare cu privire la efectele acestor perturbatori endocrini. </p>
<p class="contents">Comisia trebuie să acorde o atenţie deosebită grupurilor vulnerabile precum copiii şi femeile. Protejarea femeilor împotriva eventualelor riscuri prezentate de perturbatorii endocrini pentru sănătatea lor reproductivă este o problemă de maximă importanţă, care trebuie să fie adresată prin finanţarea, în mod prioritar, a acelor cercetări şi studii pe termen lung menite să monitorizeze sănătatea femeilor.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-406"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96786.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tadeusz Cymański (EFD), </span></span>  <span class="italic">na piśmie</span><span class="bold">. −</span> Sprawozdanie budzi zbyt wiele wątpliwości, aby można było poprzeć je w obecnym kształcie. W tym kontekście warto zwrócić również uwagę na kontrowersje, jakie budzi powierzenie Europejskiej Agencji ds. Bezpieczeństwa Żywności przygotowania sprawozdania na temat substancji wpływających na gospodarkę hormonalną u ludzi. Niestety, pojawiają się ponownie pytania dotyczące niezależności grupy ekspertów powołanych do tego zadania. Wielokrotnie już wskazywano na konflikty interesów powstające w tle prac Agencji.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-421"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/72775.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Rachida Dati (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Ce texte pose deux ambitions principales : la première, mieux protéger les Européens, et notamment les plus vulnérables, face aux risques que pourraient poser ces substances. La seconde, renforcer l'information sur ces substances, pour mieux évaluer leurs effets potentiels. Ces perturbateurs endocriniens soulèvent de grandes incertitudes : il est urgent d'y répondre et c'est pourquoi j'ai soutenu ce rapport.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-429"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4335.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marielle de Sarnez (ALDE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Les perturbateurs endocriniens, substances chimiques exogènes causant des effets néfastes sur l'organisme, peuvent être présents dans tout type de produit du quotidien, tels que les médicaments, les cosmétiques ou les additifs alimentaires. Alors que la Commission revoit actuellement sa stratégie sur les perturbateurs endocriniens, il est important, avant toute chose, de garantir un niveau de protection élevé de la santé des Européens. Respecter le principe de précaution, qui guide l'action de l'UE en matière de santé publique, implique de refuser la détermination d'un seuil minimal d'exposition en dessous duquel les perturbateurs endocriniens seraient inoffensifs, alors que l'état actuel des recherches est encore insuffisant pour en juger, et incertain par rapport aux potentiels "effets cocktails" des perturbateurs endocriniens mêlés à d'autres substances. L'approfondissement des travaux de recherche sur ces produits permettra de mieux comprendre quels sont leurs effets sur la santé humaine et de mieux se prévaloir des risques. En ce sens, les substances chimiques sur lesquelles il manque des données et présentant des propriétés perturbatrices endocriniennes, doivent être couvertes par le règlement REACH.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-437"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4347.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Christine De Veyrac (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Face aux connaissances incomplètes que nous possédons sur les effets de ces substances chimiques sur nos hormones, il est indispensable d'appliquer le principe de précaution et de mettre en place les mesures nécessaires à leur identification et à leur étude mais avant tout à leur réglementation au niveau européen. J'ai ainsi soutenu l'adoption de ce texte, qui permet de protéger la santé de nos concitoyens.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96914.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Anne Delvaux (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Je me réjouis du vote de ce rapport qui arrive au moment même où l'Organisation mondiale de la santé (OMS) publie une évaluation scientifique approfondie sur la question des perturbateurs endocriniens. Ce rapport confirme que de nombreux troubles et maladies liés au système endocrinien sont en augmentation, en ce compris les cancers du sein et de la prostate, l'infertilité et les problèmes de reproduction (baisse de la qualité du sperme des hommes, puberté précoce chez les filles), le diabète et l'obésité ainsi que les maladies neurologiques (trouble du déficit de l'attention, maladie de Parkinson). Personnellement, cela fait plus de 15 années que je m'évertue à tirer la sonnette d'alarme... je ne peux donc que me féliciter qu'enfin le Parlement européen et l'OMS se penchent sur cette bombe à retardement sanitaire que constituent ces perturbateurs endocriniens. </p>
<p class="contents">Lors du vote, j'ai également eu l'occasion de montrer mon désaccord total avec les tentatives de certains visant à introduire le critère d'"activité" en tant que seuil de définition des perturbateurs endocriniens, car cette approche limiterait indûment la définition des perturbateurs et ne concorderait pas avec la classification des substances cancérogènes, mutagènes et reprotoxiques, qui est fondée sur des preuves solides! Restons le plus vigilants possible sur ce dossier important!</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4550.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jill Evans (Verts/ALE), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> Endocrine disrupters are associated with various human health problems including reduced fertility. They can act at very low doses, which makes them especially dangerous. This is why I voted in favour of this report which calls for a reduction in human exposure to endocrine disrupters, and assessment and updating of relevant EU legislation. It is important that I use my vote in Parliament towards protecting the health of my constituents in Wales.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-687"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96899.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">José Manuel Fernandes (PPE), </span></span>  <span class="italic">por escrito</span>. <span class="bold">−</span> Estamos rodeados por desreguladores endócrinos no nosso dia-a-dia. Eles estão presentes nas embalagens dos alimentos, nos produtos para a higiene da pele, nos cosméticos, nos materiais de construção, nos produtos eletrónicos, no mobiliário e no pavimento. O sistema endócrino regula muito do que acontece no nosso corpo, nomeadamente, a reprodução, o metabolismo, o crescimento, o equilíbrio entre sal e água e a função cardíaca. Nas duas últimas décadas, têm-se verificado elementos que comprovam a existência de distúrbios hormonais no ser humano. A proteção da saúde humana é uma componente importante da política da UE (artigo 35.º do Tratado). Para tal, é importante que o princípio de precaução (artigo 191.º do Tratado) seja integralmente aplicado. O facto de não sabermos tudo não pode ser usado como pretexto para a inação. Os riscos de danos irreversíveis nos seres humanos e no ambiente são, simplesmente, demasiado grandes. Considero assim importante prever testes adequados para a identificação de desreguladores endócrinos na atual legislação da UE, especialmente no Regulamento Classificação, Rotulagem e Embalagem, no Regulamento Reach, no Regulamento Produtos Fitofarmacêuticos, na Diretiva Biocidas e na Diretiva Cosméticos.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-331-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96706.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">João Ferreira (GUE/NGL), </span></span>  <span class="italic">por escrito</span>. <span class="bold">−</span> O sistema endócrino regula um importante e alargado conjunto de funções, como a reprodução, o metabolismo, o crescimento, o equilíbrio entre sal e água e a função cardíaca. Nos últimos vinte anos, registou-se um aumento das perturbações e doenças do foro hormonal, podendo muitas destas doenças estar associadas à exposição a produtos químicos com propriedade de desregulação endócrina. A relatora considera que é necessário encarar este problema com maior seriedade e, apesar de salientar a necessidade de mais investigação para melhor compreender as causas destas doenças, considera importante que a Comissão Europeia imponha o princípio da precaução. Os riscos de danos irreversíveis nos seres humanos e no ambiente, devidos à exposição a desreguladores endócrinos, são demasiado graves. Consideramos que devem ser tomadas medidas de proteção da saúde pública, enquanto se aprofunda o conhecimento científico tanto dos efeitos e causas destas propriedades. Votámos a favor.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23868.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monika Flašíková Beňová (S&amp;D), </span></span>  <span class="italic">písomne</span><span class="bold">. −</span> Endokrinný systém reguluje veľkú časť procesov v ľudskom tele vrátane reprodukcie, metabolizmu, rastu, vyváženého pomeru medzi soľami a vodou a funkčnosti srdca. Narastá výskyt porúch, najmä pokiaľ ide o reprodukčnú schopnosť ľudí, pričom za jeden z faktorov podieľajúcich sa na tejto skutočnosti sa považujú látky narušujúce endokrinný systém. Možno pozorovať množstvo znepokojujúcich tendencií. Za posledných dvadsať rokov pribudli dôkazy o tom, že v ľudskom tele sa vyskytuje čoraz viac látok narušujúcich hormonálny systém. Na celom svete sa prudko zvýšil počet prípadov celého radu porúch a ich diagnózy. Sme svedkami rastúceho počtu deformácií pri narodení, prípadov rakoviny a cukrovky a rozmáhajú sa aj poruchy neurologického vývoja, ako je autizmus a ADHD. </p>
<p class="contents">Takéto rýchle zmeny možno vysvetliť len pôsobením vonkajších environmentálnych faktorov. Tento vplyv vonkajšieho prostredia pramení z množstva rôznych zdrojov, ku ktorým patria faktory ako životný štýl, potrava a výživa, patogénne, medicínske, farmaceutické a ekonomické faktory, ako aj sociálne príčiny ako stres. Existuje aj celý rad štúdií dokazujúcich, že podiel na tom má aj vystavenie chemickým látkam. Všetky tieto faktory môžu navzájom súvisieť. Ochrana ľudského zdravia je dôležitou súčasťou politiky EÚ (článok 35 zmluvy). Na tento účel je potrebné, aby sa v plnej miere uplatňovala zásada predbežnej opatrnosti (článok 191 zmluvy).</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/2025.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Françoise Grossetête (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> J'ai voté en faveur de cette résolution. Les perturbateurs endocriniens sont des substances naturelles ou artificielles étrangères à l'organisme capables de perturber le fonctionnement du système hormonal et d'induire des effets délétères aussi bien à court qu'à long terme sur un individu et sa descendance. Ils sont partout : dans les bouteilles en plastiques, les pesticides, les appareils électroniques, les cosmétiques et même encore dans les tétines de biberons pour enfants dans certains États membres. Sans le savoir, une femme enceinte peut exposer son enfant in utero à des risques de déséquilibre hormonal. Dans certains pays, jusqu'à 40 % des jeunes hommes ont un sperme de mauvaise qualité. Près de 800 substances chimiques sont reconnues ou suspectées d'interférer avec les récepteurs hormonaux. Cette question fera l'objet d'une proposition de règlementation européenne dans les prochains mois.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96693.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Juozas Imbrasas (EFD), </span></span>  <span class="italic">raštu</span><span class="bold">. −</span> Balsavau už šį dokumentą. Kasdieniame gyvenime nuolat susiduriame su endokrininę sistemą ardančiomis medžiagomis. Jų esama maisto pakuotėse, odos priežiūros produktuose, kosmetikoje, statybinėse medžiagose, elektronikos prekėse, balduose ir grindų dangoje. Daugelio iš plastiko pagamintų gaminių, esančių mūsų namuose ar darbo vietoje, sudėtyje yra vienos ar daugiau rūšių cheminių medžiagų, kurios, kaip įtariama, daro endokrininę sistemą ardantį poveikį. Endokrininę sistemą ardančių savybių galinčių turėti medžiagų yra daug ir jos plačiai paplitusios, o tai reiškia, kad pavieniams vartotojams neįmanoma nuo jų apsisaugoti. Todėl turi būti imtasi atitinkamų priemonių siekiant sumažinti endokrininę sistemą ardančių medžiagų poveikį žmonėms, kartu dėti daugiau pastangų atliekant tyrimus, kad būtų patikslintos turimos mokslinės žinios apie endokrininę sistemą ardančių medžiagų poveikį.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28141.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lívia Járóka (PPE), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> The number of diseases stemming from disorders of human hormonal functions is increasing year by year. Research consistently confirms that such malfunctions of the endocrine systems – which adversely affect the reproductive potential of the European population to a large extent – are mostly attributable to external factors. These triggers include for the most part lifestyle-related triggers, such as improper nutrition and stress, but endocrine disruptors are also to be found in everyday chemicals around us in furniture, food packaging, cosmetics or building materials. Children and pregnant women are highly vulnerable to such harmful effects. The Commission and the Member States must – in line with EU policies on health and prevention – seek ways to restrict the use of harmful chemicals and pay special attention to reducing the exposure of children to such substances, for example by better regulating the production of toys and the construction of education facilities. Furthermore, scientific research on ways to replace endocrine disruptors with health-neutral chemicals must be supported.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/105849.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Agnès Le Brun (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Ce rapport d'initiative, sur lequel je me suis prononcée favorablement, réagit à la forte et constante augmentation des troubles de la reproduction (tels que l'affaiblissement de la qualité du sperme, le cancer des testicules, la puberté précoce, les malformations des organes sexuels, les malformations congénitales, le cancer et le diabète en général) ainsi que des troubles neurologiques, que l'on sait désormais être dus aux perturbateurs endocriniens. Ce rapport propose donc des mesures très ambitieuses qui permettront à la fois de limiter l'utilisation de perturbateurs endocriniens dans des produits ciblés vers certains consommateurs (produits de soin de la peau, textiles, jouets,...) sans toutefois pénaliser trop lourdement les grands secteurs de l'industrie.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1403.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">David Martin (S&amp;D), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> The increased incidence of hormone-related disorders and illnesses in humans needs to be taken very seriously indeed. The endocrine system regulates much of what happens in the body, including reproduction, metabolism, growth, salt and water balance and cardiac function. There is a disturbing trend particularly with regard to human reproductive capacity, where endocrine disruptors are thought to be a contributory factor. The precautionary principle is, and must remain, a major plank of the EU’s chemicals policy. The fact that we do not know everything cannot be used as a pretext for inactivity. The risks of irreversible damage to humans and the environment are simply too great. At present there are some 27 000 research reports dealing with endocrine disruptors and their effects on humans and animals. A number of disturbing trends may be observed.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28115.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mairead McGuinness (PPE), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> The protection of human health is an important part of EU policy (Article 35 of the Treaty). I and my Fine Gael colleagues supported this non-legislative report because it calls for much greater research to improve the state of scientific knowledge on the impact of endocrine disrupters on human health. We support the development of appropriate tests for identifying endocrine disruptors and criteria on how the interpretation of these tests, in conjunction with other relevant research, might be translated into legislative measures. The EU chemical regulatory framework – notably REACH – functions by identifying substances that are dangerous and by taking measures to protect people from harm. This system works well. Only when the science and thorough impact assessments are in place should additional or new regulation be considered where the science calls for it.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-656"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96978.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nuno Melo (PPE), </span></span>  <span class="italic">por escrito</span>. <span class="bold">−</span> Há razões para encarar com a maior seriedade o aumento dos distúrbios e doenças hormonais no ser humano. O sistema endócrino regula muito do que acontece no corpo, nomeadamente, a reprodução, o metabolismo, o crescimento, o equilíbrio entre sal e água e a função cardíaca. Assiste-se a uma tendência preocupante, sobretudo no que se refere à capacidade reprodutiva do ser humano, e acredita-se que os desreguladores endócrinos desempenham um papel determinante. Grande parte do debate sobre desreguladores endócrinos diz respeito a produtos e substâncias presentes nos cosméticos, mobiliário, produtos eletrónicos, materiais de construção, brinquedos, têxteis e alimentos – incluindo as embalagens. Por isso, é importante que a Comissão reveja a atual legislação e apresente novas propostas de legislação nestes domínios, de modo a proteger as pessoas contra as substâncias desreguladoras do sistema endócrino.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-687"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28407.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Willy Meyer (GUE/NGL), </span></span>  <span class="italic">por escrito</span><span class="bold">. −</span> He votado a favor de este informe porque supone un avance en la protección efectiva de población sensible a sustancias potencialmente peligrosas para la salud. Debido a los avances científicos de los últimos años, se está comenzando a conocer la importancia de la correcta producción de hormonas y su relación con el buen funcionamiento del cuerpo. Existen numerosas enfermedades que están relacionadas con el incorrecto funcionamiento de la producción de hormonas del cuerpo. Estos nuevos avances han destacado la importancia de regular de manera mucho más exhaustiva la presencia de sustancias químicas que puedan alterar la producción de estas sustancias. Entiendo que el incremento del control de los niveles máximos de presencia de este tipo de productos químicos sintéticos que distorsionan la producción de hormonas en determinados productos de consumo es fundamental para mejorar la salud de los ciudadanos europeos. Por ello he votado a favor de este informe.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-333-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96670.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Louis Michel (ALDE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Ces vingt dernières années, nous avons pu observer une augmentation des maladies et des troubles hormonaux chez l’homme. Nos gènes n’ayant pas pu changer en si peu de temps, ce sont des facteurs externes qui en sont la cause, tels que le mode de vie, la nutrition, les médicaments, les produits chimiques, etc. La protection de la santé étant un élément-clé de la politique de l’Union européenne, il est impératif que le principe de précaution soit pleinement appliqué. Les perturbateurs endocriniens jouent un rôle important dans l’évolution préoccupante constatée et, en raison de leur omniprésence, il est impossible pour la population de s’en protéger. Il est plus que nécessaire de mettre tout en œuvre pour accroitre la protection de la santé publique et tout particulièrement celle des enfants, des jeunes et des femmes, considérés comme étant les groupes les plus sensibles. Cette résolution va dans la bonne direction en révisant l’ensemble de la législation concernée pour y inclure notamment des clauses relatives aux substances chimiques s’appliquant spécifiquement aux produits textiles, produits avec lesquels les enfants entrent souvent en contact.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-334-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28178.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Miroslav Mikolášik (PPE), </span></span>  <span class="italic">písomne</span><span class="bold">. −</span> Endokrinný systém je nevyhnutný pre správny vývoj a fungovanie organizmu. Ak dôjde k jeho narušeniu, telo musí bojovať s rôznymi problémami. Zďaleka nejde len o problém reprodukčný, hoci ten vnímame najciteľnejšie a určite ide o jednu z najzávažnejších porúch. S veľkým znepokojením počúvam správy o náraste počtu hormonálnych porúch, hoci si uvedomujem, že ide o logický následok používania chemických látok v takom rozmere, že sa im človek prakticky nemôže vyhnúť už od narodenia. Nachádzame ich v potravinách, v oblečení, v kobercoch, v pracom prášku, ktorý používame. Ide o veci, ktorými sme obklopení bez výnimky všetci, ale našou prvoradou úlohou je ochrániť deti a mladých ľudí a postarať sa o ich zdravý vývoj a plnohodnotnú dospelosť.</p>
<p class="contents">Súhlasím s pani spravodajkyňou, že je potrebné prijať opatrenia na ochranu tejto najzraniteľnejšej skupiny, do ktorej treba zarátať aj ženy v reprodukčnom veku. Takisto vyjadrujem súhlas aj s testovaním, aby sa zistila prítomnosť nebezpečných látok, a s revíziou príslušnej legislatívy.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-334-125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96999.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Alexander Mirsky (S&amp;D), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> Even if not all open questions can be answered now, it is time to act in accordance with the precautionary principle.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-334-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28255.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Andreas Mölzer (NI), </span></span>  <span class="italic">schriftlich</span>. <span class="bold">−</span> Als endokrine Disruptoren bezeichnet man chemische Substanzen, die auf Grund ihrer Struktur und Wirkungsweise auf Organismen ähnlich wie Hormone wirken oder den Hormonhaushalt beeinflussen. Durch die Einwirkung endokriner Disruptoren wurden schädliche Wirkungen auf die Fortpflanzung, das Wachstum und die Entwicklung gewisser Tierarten beobachtet, sowie die Tatsache, dass die Anzahl mancher Störungen des menschlichen Fortpflanzungssystems und gewisser Krebsarten zugenommen hat. Dies führt man auf eine Störung des endokrinen Systems zurück. Für den Menschen sind folgende Auswirkungen zu befürchten: ein Rückgang der männlichen Fruchtbarkeit, Missbildungen der männlichen Genitalien, Krankheiten des weiblichen Fortpflanzungssystems, Frühpubertät, und ein Rückgang der Anzahl geborener Jungen. Auch im Tierreich machen sich ähnliche Symptome bemerkbar. Ich habe für diese Entschließung gestimmt, da es unabdingbar ist, in dem Bereich der endokrinen Disruptoren weitere, tiefgreifende Forschungen durchzuführen, um die bis dato vermuteten Schädigungen entweder bestätigen oder widerlegen zu können.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-334-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/39714.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Rareş-Lucian Niculescu (PPE), </span></span>  <span class="italic">în scris</span><span class="bold">. −</span> Am votat în favoarea raportului referitor la protectia sănătătii publice împotriva perturbatorilor endocrini şi voi susţine întotdeauna aplicarea principiului prudenţei în utilizarea produselor chimice, indiferent de domeniu. Organismele publice au datoria de a suplini, prin prudenţă şi printr-o informare cât mai completă, lipsa de cunoştinţe a publicului consumator în privinta potenţialelor efecte adverse ale unor substanţe chimice. Consider că în situaţiile în care aceste substanţe chimice sunt componente ale unor produse alimentare, principiul prudenţei trebuie să aibă întâietate faţă de orice alte considerente, indiferent care ar fi acestea.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-334-625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96694.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Rolandas Paksas (EFD), </span></span>  <span class="italic">raštu</span><span class="bold">. −</span> Pritariu šiai rezoliucijai. Atsižvelgiant į tai, kad pavieniams vartotojams neįmanoma apsisaugoti nuo šių medžiagų, būtina nustatyti griežtesnius saugumo reikalavimus. ES mastu turėtų būti apribotas endokrininę sistemą ardančių medžiagų naudojimas gaminiuose, skirtuose konkrečioms tikslinėms grupėms. Labai svarbu, kad endokrininę sistemą ardančios medžiagos būtų priskiriamos prie ribinių verčių neturinčių medžiagų grupės, kadangi jos gali itin stipriai pažeisti žmogaus imuninę sistemą. Be to, turi būti parengtos konkrečios priemonės, susijusios su konkrečiais moksliniais kriterijais, skirtais endokrininei sistemai kenkiančiomis savybėmis nustatyti.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-334-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97050.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Antigoni Papadopoulou (S&amp;D), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> Endocrine disruptors are substances that are associated with various human health problems. They are present in food packaging, skincare products, cosmetics, building materials, electronic goods, furniture and floorings. It is impossible for a consumer to know what substances are present in what products, particularly in the case of goods with no list of ingredients. It is important to restrict the use of endocrine disruptors in products aimed at specific target groups, such as skincare products, textiles and toys with specific areas of application. More stringent safety requirements could also be applied when building and furnishing pre-schools and schools and other premises where children stay for prolonged periods. A coherent definition and strictly defined criteria for their use are lacking, which are necessary preconditions to better regulating those chemicals. I voted in favour of this report because amongst other matters, it underlines that legal measures need to be taken to effectively lower the exposure of humans to EDCs. It stresses the need for criteria for EDCs to be based on hazard assessment, as no safe thresholds can be set. In general, greater emphasis should be put on the precautionary principle in the ongoing review of the EU’s strategy on EDs.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-334-812"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96902.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Maria do Céu Patrão Neves (PPE), </span></span>  <span class="italic">por escrito</span>. <span class="bold">−</span> O presente relatório baseia-se em factos provenientes de uma série de fontes. Na Conferência sobre desreguladores endócrinos, realizada pela Comissão em Bruxelas em junho de 2012, foram feitas várias apresentações valiosas para o presente relatório que conclui pela necessidade de se preverem testes adequados para a identificação de desreguladores endócrinos na atual legislação da UE, especialmente no Regulamento Classificação, Rotulagem e Embalagem, no Regulamento Reach, no Regulamento Produtos Fitofarmacêuticos, na Diretiva Biocidas e na Diretiva Cosméticos. Sendo claras as conclusões e os objetivos do relatório, votei-o positivamente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-334-875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96903.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Paulo Rangel (PPE), </span></span>  <span class="italic">por escrito</span>. <span class="bold">−</span> Nos últimos vinte anos, registou-se um aumento abrupto dos distúrbios e doenças do foro hormonal em humanos e na fauna selvagem. Uma vez que os genes não mudaram num tão curto espaço de tempo, este aumento só pode ser explicado por fatores ambientais externos. Apesar da acentuada dificuldade em demonstrar uma relação de causalidade entre substâncias químicas e distúrbios do equilíbrio hormonal, segundo vários estudos, a exposição a produtos químicos é um fator determinante nos efeitos adversos à saúde humana e animal. Considerando o princípio de precaução, a presente proposta de resolução exorta a Comissão a elaborar legislação que garanta a aplicação horizontal dos critérios de identificação de desreguladores endócrinos conhecidos, prováveis e potenciais, de modo a alcançar um elevado nível de proteção. Neste sentido, a ausência de conhecimentos exatos não nos deve impedir de tomar medidas de proteção da saúde, sendo importante restringir o uso das substâncias químicas com propriedades de desregulação do sistema endócrino em produtos destinados a grupos-alvo específicos, como os produtos para a higiene da pele, os produtos têxteis e os brinquedos para determinados fins. Por considerar fundamental a proteção da saúde humana e a proteção da fauna selvagem e do ambiente, votei favoravelmente este relatório.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-335-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/4253.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Frédérique Ries (ALDE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Les perturbateurs endocriniens, substances chimiques particulièrement présentes dans notre vie quotidienne, ont été les grands oubliés du règlement REACH adopté en 2006, sur les produits chimiques. C'est un fâcheux oubli, dans la mesure où de plus en plus de voix scientifiques s'élèvent contre la dangerosité de ces substances, associées à des malformations génitales et à la forte progression des cancers hormono-dépendants, comme les cancers de la prostate et du sein, la puberté précoce des filles, etc. </p>
<p class="contents">Tour à tour, nous y sommes exposés, via notre alimentation, notre respiration et notre peau, puisqu'on les trouve principalement dans les cosmétiques (parabens), dans les plastiques (Bisphénol A et phtalates) et dans les détergents (alkylphénols). Et mis à part l'interdiction du bisphénol A dans les biberons et de certains phtalates dans les jouets, les perturbateurs endocriniens continuent à circuler librement. </p>
<p class="contents">Pour toutes ces raisons, et aussi pour délivrer un message clair à la Commission qui planche actuellement sur une définition des PTB, le vote de ce midi sur le rapport Westlund est important. Il souligne en particulier l'urgence de mettre en place des tests de toxicité qui tiennent compte des périodes particulièrement vulnérables du développement comme la grossesse.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-335-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97022.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Robert Rochefort (ALDE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Ces vingt dernières années, les cas de maladies et de troubles hormonaux ont augmenté chez l'Homme, entraînant notamment de nombreux problèmes de procréation, la fréquence élevée de certains cancers, ainsi que la multiplication des troubles métaboliques. Or un nombre croissant d'études scientifiques suggèrent que les perturbateurs endocriniens chimiques (pesticides, additifs plastiques, stéroïdes, etc.) jouent un rôle en la matière, bien qu'il soit encore difficile d'établir un lien de causalité irréfutable entre une exposition à différentes substances chimiques et une perturbation de l'équilibre hormonal susceptible d'avoir des effets nuisibles sur la santé. Dans ce contexte, il me paraît fondamental d'accélérer la recherche afin de lever les points d'interrogation qui subsistent, tout en prenant des mesures pour protéger la santé humaine. Le principe de précaution doit guider l'action politique dans ce domaine et il me parait crucial que les règles actuelles soient examinées en profondeur en vue d'une mise à jour rapide. En outre, les consommateurs doivent disposer d'informations claires et fiables sur les dangers potentiels des perturbateurs endocriniens, leurs effets et la possibilité de s'en protéger, et la Commission aussi bien que les États membres devraient agir en ce sens. C'est le sens de cette résolution, à laquelle j'apporte mon soutien.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-335-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28409.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Raül Romeva i Rueda (Verts/ALE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Pour. On ne peut plus se permettre d'attendre pour agir. Le risque de maladies dues aux perturbateurs endocriniens est largement sous-estimé, et tous les jours, nous continuons à être exposés à ces substances, par le biais de notre alimentation ou par contact direct, à la ville comme à la campagne. </p>
<p class="contents">Il est donc urgent de donner une définition claire et large de ces substances dangereuses afin de diminuer le risque d'exposition et de protéger les populations les plus à risque comme les femmes enceintes, le fœtus et les enfants. En effet, les femmes enceintes pénalisent sans le savoir la santé de leurs enfants avant même qu'ils naissent. Il faut donc que les pouvoirs publics informent la population par le biais de campagnes d'information nationales très claires: attention aux revêtements (du sol par exemple) en PVC, aux vernis de certains meubles, des boîtes de conserve qui contiennent du bisphénol A, ou aux produits cosmétiques qui peuvent également contenir ces perturbateurs endocriniens. </p>
<p class="contents">Nous nous félicitons que le lobby de l'industrie chimique, puissant et très présent dans les couloirs des institutions européennes, n'ait pas réussi à faire modifier les demandes clés du rapport, souligne la députée européenne.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-335-562"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96819.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Licia Ronzulli (PPE), </span></span>  <span class="italic">per iscritto</span><span class="bold">. −</span> E' necessario intervenire con determinazione introducendo un giro di vite per le sostanze chimiche che colpiscono gli ormoni, riducendo l'esposizione ai cosiddetti "interferenti endocrini". Negli ultimi vent'anni sempre più persone hanno cominciato a soffrire in Europa di disturbi ormonali. Bisogna agire subito, intervenendo nei confronti di tutti gli interferenti endocrini potenziali come gli ormoni steroidei, alcuni pesticidi, le diossine e gli additivi plastici.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-335-625"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97196.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Oreste Rossi (EFD), </span></span>  <span class="italic">per iscritto</span><span class="bold">. −</span> Sono contrario al testo di relazione che s'inserisce nel contesto dei lavori per la definizione dei criteri per l'identificazione delle sostanze interferenti endocrine, in quanto assume un tono eccessivamente allarmistico: infatti, l'approccio basato sul pericolo e pertanto sull'applicazione aprioristica del principio di precauzione potrebbe portare al divieto indiscriminato di interi gruppi di sostanze chimiche che, al contrario, potrebbero dimostrarsi sicure.</p>
<p class="contents">Insomma, la prospettiva è quella di considerare le reazioni del sistema endocrino alle sostanze chimiche (naturali o di sintesi) come pericolose a priori. Un approccio più sensato dovrebbe invece essere fondato sulle definizioni di "interferente endocrino" e di "effetto avverso" dell'OMS, con una valutazione caso per caso sulla base di criteri definiti a livello ONU. Ritengo indispensabile valutare una soglia per ogni sostanza chimica, oltre la quale, secondo le evidenze scientifiche, si possono porre rischi per la salute dei cittadini.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-335-656"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/99416.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nikolaos Salavrakos (EFD), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> The increased incidence of hormone-related disorders and illnesses in humans needs to be taken very seriously indeed. The endocrine system regulates much of what happens in the body, including reproduction, metabolism, growth, salt and water balance and cardiac function. There is a disturbing trend particularly with regard to human reproductive capacity, where endocrine disruptors are thought to be a contributory factor. I voted in favour of this report because endocrine disruptors influence the human environment, and if not addressed quickly can create irreversible damage to humans and the environment.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-335-687"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96755.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sergio Paolo Francesco Silvestris (PPE), </span></span>  <span class="italic">per iscritto</span><span class="bold">. −</span> La tutela della salute costituisce un elemento importante delle politiche dell’UE così come sancito dall’articolo 35 del trattato, e strettamente legata al principio di precauzione (articolo 191). Negli ultimi anni si è registrato un aumento delle patologie legate a disfunzioni ormonali che hanno causato problematiche più o meno gravi quali l’impossibilità del concepimento, o l’aumento dell’incidenza del cancro al seno che, negli Stati Uniti, ha registrato dal 1980 ad oggi un raddoppiamento delle casistiche. Tale dato non può essere legato soltanto a cambiamenti genetici, ma è indubbia una incidenza di fattori esterni quali le abitudini di vita, l’uso di droghe, lo stress o una cattiva alimentazione o la combinazione di alcuni di essi. Pertanto, è innegabile la presenza di interferenti endocrini, sui quali però è difficile intraprendere una indagine accurata che metta in relazione cause ed effetti, ma è impossibile per il consumatore proteggersi, data la capillare diffusione degli stessi in molti ambiti della nostra vita quotidiana. Sono favorevole alla presente risoluzione che propone di rivedere e sviluppare tutta la legislazione pertinente, disponendo controlli più mirati su particolari tipi di prodotti come quelli destinati ai bambini, e magari predisponendo una classificazione degli interferenti endocrini.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-335-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96655.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Monika Smolková (S&amp;D), </span></span>  <span class="italic">písomne</span><span class="bold">. −</span> Zdravie človeka závisí od jeho imunity, čiže od jeho odolnosti voči nákazám a schopnosti včas zneškodniť nákazu. Chcem vysloviť poďakovanie za to, že EÚ v poslednom období venuje čoraz väčšiu pozornosť výskumu chemikálií, ktoré narúšajú hormonálny systém už pri malých dávkach nielen u človeka, ale aj u zvierat. O opodstatnenosti riešenia tohto problému svedčí aj to, že v ľudskom tele sa vyskytuje čoraz viac látok narúšajúcich hormonálny systém a tieto látky zasahujú do tvorby a činnosti hormónov.</p>
<p class="contents">Podporila som správu vrátane návrhov na opatrenia, pretože riziká nenapraviteľného poškodenia ľudského zdravia a životného prostredia sú píliš vysoké. Očakávam, že Komisia oveľa dôslednejšie posúdi terajšie právne úpravy a v prípade ich neaktuálnosti navrhne primerané úpravy a usmernenia, tak aby sa zohľadnili rizika vyplývajúce z látok narúšajúcich endokrinný systém. Vítam a podporujem prijatie takých opatrení, ktorými by sa čo najviac znížilo vystavenie ľudí látkam narúšajúcim endokrinný systém. Verím, že v budúcnosti nám takéto opatrenia prinesú udržateľný chemický priemysel, lepšiu ochranu životného prostredia a zdravie budúcich generácií.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-336-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/111026.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ewald Stadler (NI), </span></span>  <span class="italic">schriftlich</span>. <span class="bold">−</span> Ich bin dankbar für den Bericht über den Schutz der öffentlichen Gesundheit vor endokrinen Disruptoren. Endlich werden die gefährlichen Konsequenzen der übermäßigen Hormonbelastung politisch ernst genommen. Eine wesentliche Ursache für die nun zu Tage tretenden Gesundheitsrisiken enthält uns der Bericht leider vor. Es ist erwiesen, dass insbesondere die Pharmaindustrie im Zusammenhang mit dem vermehrten Auftreten hormonbezogener Störungen große Mitschuld trägt. Problematisch ist vor allem das Pillenhormon EE2, welches einer der allerstärksten endokrinen Disruptoren überhaupt ist. Es findet in der Regel in hormonellen Verhütungsmitteln Verwendung. Das EE2 in den pro Tag mehr als sechs Millionen Mal geschluckten Ovulationshemmern dominiert völlig den ungewollten Haupteintrag ins Abwasser und in der Folge davon leider auch ins Grundwasser bis hinein ins Trinkwasser. EE2 ist um das Tausendfache stärker als Bisphenol A oder als Nonylphenol und millionenfach stärker als der endokrine Disruptor 3-Benzylidencampher. Eine Novellierung der REACH-Verordnung ist überfällig. Sie schreibt für bestimmte Problemstoffe eine Überprüfung leider erst dann vor, wenn die jährliche Produktionsmenge zehn Tonnen übersteigt. Die Produkutionsmenge von EE2 liegt jedoch darunter, so dass ausgerechnet der schlimmste Stoff durch das Raster der REACH-Verordnung fällt. Daher sehe ich den vorliegenden Bericht kritisch.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-337-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/29579.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marc Tarabella (S&amp;D), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Je soutiens ce rapport pour plusieurs raisons. D'abord, des mesures de précaution visant à protéger la santé humaine doivent être mises en œuvre lorsqu'on peut raisonnablement admettre l'existence d'effets néfastes produits par des perturbateurs endocriniens. Les critères utilisés pour définir la perturbation endocrinienne doivent s'appuyer sur des évaluations exhaustives des dangers, adossées aux derniers développements scientifiques et tenant compte des combinaisons potentielles ainsi que des effets à long terme. À partir de là, l'évaluation des dangers doit constituer la base de l'évaluation des risques et des mesures de gestion des risques.</p>
<p class="contents">Ensuite, la Commission est priée d'effectuer un examen systématique de toute la législation concernée et, le cas échéant, d'amender les lois existantes ou de présenter de nouvelles propositions législatives d'ici juin 2015, afin de les réduire aux substances chimiques perturbatrices du système endocrinien. Les perturbateurs endocriniens doivent être considérés comme "substances sans effet de seuil", à moins que les producteurs apportent des preuves scientifiques de la présence d'un seuil sous lequel aucun effet néfaste ne se produit. </p>
<p class="contents">Enfin, la Commission est priée de développer des méthodologies réduisant au minimum les essais sur animaux.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-337-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96974.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Nuno Teixeira (PPE), </span></span>  <span class="italic">por escrito</span>. <span class="bold">−</span> Os desreguladores das glândulas endócrinas, presentes em produtos cosméticos, têxteis e brinquedos, são conhecidos pelo risco de despoletar doenças no aparelho reprodutivo, nomeadamente deformações e cancros. Os desreguladores endócrinos são também responsáveis por doenças neurológicas e diabetes. A relatora defende fortes medidas de fiscalização e análises químicas no que diz respeito ao uso de produtos que contenham tais desreguladores. Dado que o presente relatório visa a proteção da saúde pública e que o mesmo se baseia extensamente em pesquisa científica, bem como em pareceres da Organização Mundial de Saúde, votei favoravelmente o presente relatório.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-337-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/30475.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Justina Vitkauskaite (ALDE), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> Over the past twenty years the rate of hormone-related disorders and illnesses has constantly risen. The increase in such disorders is explained by external factors such as lifestyle, and economic factors, nutrition, pathogens, drugs and other social causes such as stress. There is another factor which has been proven by a wide range of studies that can contribute to hormone-related disorders: exposure to endocrine-disrupting chemicals. The impact of chemical exposure is not immediately visible but can lead to an increased risk of hormonal disturbances, reduced fertility and reproductive abnormalities and can be particularly dangerous for pregnant women, children and young people. This Parliament report calls for a reduction in exposure to these chemicals and provides an input for assessing relevant EU legislation, putting emphasis on the precautionary principle in the ongoing review of the EU’s strategy on endocrine disruptors. I welcome this report and consider that further appropriate measures need to be taken in order to identify endocrine disruptors, harmonise new testing methods and establish criteria for regulation. Only concrete legislative measures can lead to the protection of citizens from substances with endocrine-disrupting properties and in turn could help to decrease hormone-related disorders linked to them.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-337-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97016.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Angelika Werthmann (ALDE), </span></span>  <span class="italic">schriftlich</span>. <span class="bold">−</span> Die Zunahme hormoneller Störungen und Krankheiten beim Menschen ist sehr ernst zu nehmen. Ein wichtiger Teil der EU-Chemikalienpolitik ist das Vorsorgeprinzip, dieses sollte man nicht vergessen. Besonders ist eine Zunahme bei potenziell reproduktionsbezogenen Krankheiten in Form von verschlechterter Spermienqualität, Hodenkrebs, verfrüht einsetzender Pubertät und missgestalteten Geschlechtsorganen feststellbar. Des Weiteren gibt es eine Zunahme bei angeborenen Missbildungen, Krebsarten und Diabeteserkrankungen sowie bei Fällen von neurologischen Entwicklungsstörungen wie Autismus und ADHD zu verzeichnen. Eine derartige rapide Veränderung ist auf äußere Faktoren zurückzuführen. Zu den äußeren Faktoren zählen Lebensstilfaktoren, Ernährung, Krankheitserreger, Arzneimittel, Aussetzung gegenüber Chemikalien, Drogen, wirtschaftliche Faktoren und soziale Ursachen wie beispielsweise Stress. All diese Faktoren können sich gegenseitig beeinflussen. Eine wichtige Aufgabe der EU liegt im Schutz der menschlichen Gesundheit, dazu muss man das Vorsorgeprinzip zur Anwendung bringen. Im Alltag ist man ständig von hormonstörenden Stoffen umgeben, wie z. B. bei Verpackungen. Besonders gefährdet sind Kleinkinder, ebenso Jugendliche und Frauen im gebärfähigen Alter.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-338-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/35743.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Glenis Willmott (S&amp;D), </span></span>  <span class="italic">in writing</span><span class="bold">. −</span> An endocrine disruptor is a substance which alters the function of the body’s hormone system, causing adverse health effects. I supported this own initiative report, which calls on the Commission to carry out further research and review relevant legislation in order to reduce human exposure to these chemicals. The proposals put forward include ensuring that legislation is based on comprehensive, scientific assessments and that no upper limit is set for such chemicals unless manufacturers can demonstrate that they are safe using scientific evidence. It also asks the Commission to develop research methods that minimise animal testing. Endocrine disruptors are found in many everyday household products, such as detergents, plastics, cosmetics and food packaging and there is evidence linking them to a number of diseases and hormone-related disorders. Consumers have a right to expect the highest possible safety standards for everything they buy in Europe and it is therefore essential that we take measures to restrict any exposure to these harmful substances.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-339-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96802.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jacek Włosowicz (EFD), </span></span>  <span class="italic">na piśmie</span><span class="bold">. −</span> Odnotowany w ostatnich latach wzrost liczby przypadków zaburzeń i chorób hormonalnych u ludzi należy traktować bardzo poważnie. Układ endokrynologiczny reguluje bowiem wiele funkcji organizmu, między innymi rozmnażanie, metabolizm, wzrost, gospodarkę wodno-mineralną oraz funkcjonowanie serca. Obserwuje się niepokojące zmiany, zwłaszcza w odniesieniu do rozrodczości, z którymi substancje zaburzające gospodarkę hormonalną zdają się mieć duży związek. Podstawową zasadą unijnej polityki dotyczącej chemikaliów jest i powinna pozostać zasada ostrożności. Brak całkowitej wiedzy nie może być wymówką dla pasywności. Ryzyko nieodwracalnych zmian w środowisku i organizmie człowieka jest po prostu zbyt wysokie. Obecnie istnieje około 27 000 sprawozdań naukowych na temat substancji zaburzających gospodarkę hormonalną i ich wpływu na ludzi i zwierzęta. Zachorowalność i wykrywalność szeregu chorób wzrastają lawinowo na całym świecie. Szczególną uwagę przyciąga coraz częstsze występowanie dolegliwości potencjalnie związanych z rozrodczością, ale obserwuje się także wzrost liczby uszkodzeń płodów, zachorowań na nowotwory i cukrzycę, rośnie również liczba przypadków neurologicznych chorób rozwojowych, takich jak autyzm i ADHD. Jak widać problem jest na tyle istotny, że nie można przejść obok niego obojętnie.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-339-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/111589.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Inês Cristina Zuber (GUE/NGL), </span></span>  <span class="italic">por escrito</span>. <span class="bold">−</span> Nos últimos vinte anos, registou-se um aumento das perturbações e doenças do foro hormonal, podendo muitas destas doenças estar associadas à exposição a produtos químicos com propriedade de desregulação endócrina. A relatora considera que é necessário encarar este problema com maior seriedade e, apesar de salientar a necessidade de mais investigação para melhor compreender as causas destas doenças, considera importante que a Comissão Europeia imponha o princípio da precaução. Os riscos de danos irreversíveis nos seres humanos e no ambiente, devido à exposição a desreguladores endócrinos, são demasiado graves. Consideramos que devem ser tomadas medidas de proteção da saúde pública, enquanto se aprofunda o conhecimento científico tanto dos efeitos e causas destas propriedades.</p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td></td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
